Your browser doesn't support javascript.
loading
Toward a drug development path that targets metastatic progression in osteosarcoma.
Khanna, Chand; Fan, Timothy M; Gorlick, Richard; Helman, Lee J; Kleinerman, Eugenie S; Adamson, Peter C; Houghton, Peter J; Tap, William D; Welch, Danny R; Steeg, Patricia S; Merlino, Glenn; Sorensen, Poul H B; Meltzer, Paul; Kirsch, David G; Janeway, Katherine A; Weigel, Brenda; Randall, Lor; Withrow, Stephen J; Paoloni, Melissa; Kaplan, Rosandra; Teicher, Beverly A; Seibel, Nita L; Smith, Malcolm; Uren, Aykut; Patel, Shreyaskumar R; Trent, Jeffrey; Savage, Sharon A; Mirabello, Lisa; Reinke, Denise; Barkaukas, Donald A; Krailo, Mark; Bernstein, Mark.
Affiliation
  • Khanna C; Molecular Oncology Section, Metastasis Biology; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Fan TM; Department of Veterinary Clinical Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois; t-fan@illinois.edu.
  • Gorlick R; Department of Pediatrics and Molecular Pharmacology, The Albert Einstein College of Medicine of Yeshiva University; Division of Hematology/Oncology, Department of Pediatrics, The Children's Hospital at Montefiore, Bronx;
  • Helman LJ; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Kleinerman ES; Cancer Biology and.
  • Adamson PC; Division of Clinical Pharmacology & Therapeutics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania;
  • Houghton PJ; Center for Childhood Cancer, The Research Institute, Nationwide Children's Hospital, Columbus, Ohio;
  • Tap WD; Sarcoma Oncology, Melanoma and Sarcoma Service, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York; Departments of.
  • Welch DR; Kansas University Medical Center, Kansas City, Kansas;
  • Steeg PS; Laboratory of Molecular Pharmacology; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Merlino G; Laboratory of Cancer Biology and Genetics; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Sorensen PH; Department of Pathology, University of British Columbia; BC Cancer Research Centre, Vancouver, British Columbia; and.
  • Meltzer P; Genetics Branch; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Kirsch DG; Pharmacology & Cancer Biology, Duke University Medical Center, Durham, North Carolina;
  • Janeway KA; Department of Pediatrics, Harvard Medical School; Pediatric Oncology, Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts;
  • Weigel B; Department of Pediatrics, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota;
  • Randall L; Huntsman Cancer Institute & Primary Children's Medical Center, University of Utah, Salt Lake City, Utah;
  • Withrow SJ; Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado; Departments of.
  • Paoloni M; Comparative Oncology Program; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Kaplan R; Tumor Microenvironment Section, Pediatric Oncology Branch; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Teicher BA; Molecular Pharmacology Branch; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Seibel NL; Cancer Therapy Evaluations Program; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Smith M; National Cancer Institute, NIH, Bethesda, Maryland;
  • Uren A; Oncology and Biochemistry and Molecular & Cellular Biology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia;
  • Patel SR; Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas;
  • Trent J; Translational Genomics Research Institute (TGen), Phoenix, Arizona;
  • Savage SA; Clinical Genetics Branch; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Mirabello L; Genetic Epidemiology Branch, Division of Cancer Epidemiology and Genetics; Center for Cancer Research; National Cancer Institute, NIH, Bethesda, Maryland;
  • Reinke D; University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan;
  • Barkaukas DA; Children's Oncology Group, QuadW-COG Childhood Sarcoma Biostatistics and Annotation Office, Monrovia;
  • Krailo M; Department of Preventive Medicine, Keck School of Medicine at the University of Southern California, Los Angeles, California;
  • Bernstein M; Department of Pediatrics, IWK Health Centre, Dalhousie University, Halifax, Nova Scotia, Canada.
Clin Cancer Res ; 20(16): 4200-9, 2014 Aug 15.
Article in En | MEDLINE | ID: mdl-24803583
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / Disease Models, Animal / Drug Evaluation, Preclinical / Antineoplastic Agents Language: En Journal: Clin Cancer Res Year: 2014 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Neoplasms / Osteosarcoma / Disease Models, Animal / Drug Evaluation, Preclinical / Antineoplastic Agents Language: En Journal: Clin Cancer Res Year: 2014 Type: Article